Selected article for: "antiviral development and Ebola virus"

Author: Badolo, Athanase; Burt, Felicity; Daniel, Susan; Fearns, Rachel; Gudo, Eduardo Samo; Kielian, Margaret; Lescar, Julien; Shi, Yi; von Brunn, Albrecht; Weiss, Susan R.; Hilgenfeld, Rolf
Title: Third Tofo Advanced Study Week on Emerging and Re-emerging Viruses, 2018
  • Cord-id: 1sm49i5r
  • Document date: 2018_12_28
  • ID: 1sm49i5r
    Snippet: The Third Tofo Advanced Study Week on Emerging and Re-Emerging Viruses (3rd TASW) was held in Praia do Tofo, Mozambique, from September 02 to 06, 2018. It brought together 55 participants from 10 African countries as well as from Belgium, China, Germany, Singapore, and the USA. Meeting sessions covered aspects of the epidemiology, diagnosis, molecular and structural biology, vaccine development, and antiviral drug discovery for emerging RNA viruses that are current threats in Africa and included
    Document: The Third Tofo Advanced Study Week on Emerging and Re-Emerging Viruses (3rd TASW) was held in Praia do Tofo, Mozambique, from September 02 to 06, 2018. It brought together 55 participants from 10 African countries as well as from Belgium, China, Germany, Singapore, and the USA. Meeting sessions covered aspects of the epidemiology, diagnosis, molecular and structural biology, vaccine development, and antiviral drug discovery for emerging RNA viruses that are current threats in Africa and included flaviviruses (dengue and Zika), alphaviruses (chikungunya), coronaviruses, filoviruses (Ebola), influenza viruses, Crimean Congo hemorrhagic fever virus, Rift Valley fever Virus, Lassa virus, and others. Data were presented on recent flavivirus and/or chikungunyavirus outbreaks in Angola, Burkina Faso, and Mozambique. In addition, these viruses are endemic in many sub-Saharan countries. The TASW series on emerging viruses is unique in Africa and successful in promoting collaborations between researchers in Africa and other parts of the world, as well as among African scientists. This report summarizes the lectures held at the meeting and highlights advances in the field.

    Search related documents:
    Co phrase search for related documents
    • accessory protein and acute disease: 1, 2, 3, 4, 5
    • accessory protein and acute respiratory infection: 1, 2, 3
    • accessory protein and addition time: 1, 2
    • acting antiviral and acute disease: 1, 2, 3, 4, 5
    • acting antiviral and acute respiratory infection: 1, 2, 3
    • acting antiviral and addition time: 1, 2, 3
    • active passive and acute disease: 1, 2, 3, 4, 5, 6
    • active passive and acute fever: 1
    • active passive and acute respiratory infection: 1
    • active site and acute disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • active site and acute disease cause: 1, 2
    • active site and acute fever: 1
    • active site and acute respiratory infection: 1, 2, 3, 4, 5, 6
    • acute disease and addition time: 1, 2, 3, 4, 5, 6, 7, 8
    • acute fever and addition time: 1
    • acute respiratory infection and addition time: 1, 2, 3, 4, 5